Motley Fool Speculates About Fresenius Purchase of NxStage
Will NxStage stock price volatility affect he sale of NxStage to purchaser Fresenius Medical Care? Time will tell, and revenues are up, but profits are not.
Read the full article » | Posted 06-12-2018
Related Articles
- Death of Cannulation Expert, Educator and Home Dialysis Champion, Stuart Mott Posted 07-12-2024
- PD and Home HD Sessions and Posters from the 2024 NKF Spring Clinicals Posted 06-14-2024
- New, Validated Survey of Home Dialysis Patients’ Experience of Care Posted 06-14-2024
- Baxter Launches MyPD Digital Management App in Korea Posted 06-14-2024